ATNM Feb 2025 7.500 call
| Previous Close | 1.8500 |
| Open | 1.8500 |
| Bid | 1.7000 |
| Ask | 2.2500 |
| Strike | 7.50 |
| Expire Date | 2025-02-21 |
| Day's Range | 1.8500 - 1.8500 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 34 |
ZacksIs Actinium Pharmaceuticals (ATNM) Outperforming Other Medical Stocks This Year?
Here is how Actinium Pharmaceuticals (ATNM) and Encompass Health (EHC) have performed compared to their sector so far this year.
NewsfileTreatment of Blood Cancers - Biopharma Companies Building out their Pipeline of Solutions
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - June 18, 2024) - Investorideas.com, a go-to investing platform covering biotech and medical technology stocks releases the second of a two-part series looking at developments for the treatment of blood cancers, including AML, featuring Actinium Pharmaceuticals, Inc. (NYSE American: ATNM). Actinium is a leader in the development of Antibody Radiation Conjugates (ARCs) and other targeted radiotherapies.Read the full article on Inve
NewsfileBiopharma Stocks Quest for Solutions for Acute Myeloid Leukemia (AML)
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - June 17, 2024) - Investorideas.com, a go-to investing platform, releases the first of a two-part series looking at developments for the treatment of blood cancers. Today's snapshot focuses in on acute myeloid leukemia (AML) and the companies developing innovative solutions, featuring Actinium Pharmaceuticals, Inc. (NYSE American: ATNM). Actinium is a leader in the development of Antibody Radiation Conjugates (ARCs) and other targ
